Patents by Inventor Antti I. Nykänen

Antti I. Nykänen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GROWTH FACTOR ANTAGONISTS FOR ORGAN TRANSPLANT ALLOIMMUNITY AND ARTERIOSCLEROSIS
    Publication number: 20210395339
    Abstract: The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors, to prevent, inhibit, or ameliorate allograft rejection or arteriosclerosis in organisms that receive an organ transplant.
    Type: Application
    Filed: January 20, 2021
    Publication date: December 23, 2021
    Inventors: Kari Alitalo, Karl B. Lemström, Antti I. Nykänen
  • GROWTH FACTOR ANTAGONISTS FOR ORGAN TRANSPLANT ALLOIMMUNITY AND ARTERIOSCLEROSIS
    Publication number: 20180118804
    Abstract: The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors, to prevent, inhibit, or ameliorate allograft rejection or arteriosclerosis in organisms that receive an organ transplant.
    Type: Application
    Filed: November 21, 2017
    Publication date: May 3, 2018
    Applicant: VEGENICS PTY LIMITED
    Inventors: Kari Alitalo, Karl B. Lemström, Antti I. Nykänen
  • Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis
    Patent number: 9896499
    Abstract: The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors, to prevent, inhibit, or ameliorate allograft rejection or arteriosclerosis in organisms that receive an organ transplant.
    Type: Grant
    Filed: April 15, 2015
    Date of Patent: February 20, 2018
    Assignee: VEGENICS PTY LIMITED
    Inventors: Kari Alitalo, Karl B. Lemström, Antti I. Nykänen
  • GROWTH FACTOR ANTAGONISTS FOR ORGAN TRANSPLANT ALLOIMMUNITY AND ARTERIOSCLEROSIS
    Publication number: 20150218249
    Abstract: The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors, to prevent, inhibit, or ameliorate allograft rejection or arteriosclerosis in organisms that receive an organ transplant.
    Type: Application
    Filed: April 15, 2015
    Publication date: August 6, 2015
    Inventors: Kari Alitalo, Karl B. Lemström, Antti I. Nykänen
  • Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis
    Patent number: 9073997
    Abstract: The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors, to prevent, inhibit, or ameliorate allograft rejection or arteriosclerosis in organisms that receive an organ transplant.
    Type: Grant
    Filed: February 1, 2008
    Date of Patent: July 7, 2015
    Assignee: VEGENICS PTY LIMITED
    Inventors: Kari Alitalo, Karl B. Lemström, Antti I. Nykänen